The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients

Autor Benoist, Guillemette E., van Oort, Inge M., Burger, David M., Mehra, Niven, van Erp, Nielka P.
Vydáno v Cancer Chemother Pharmacol (2020)

Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy

Autor Somford, Diederik M., van Oort, Inge M., Cosyns, Jean-Pierre, Witjes, J. Alfred, Kiemeney, Lambertus A. L. M., Tombal, Bertrand
Vydáno 2011

PREDICT: model for prediction of survival in localized prostate cancer

Autor Kerkmeijer, Linda G. W., Monninkhof, Evelyn M., van Oort, Inge M., van der Poel, Henk G., de Meerleer, Gert, van Vulpen, Marco
Vydáno v World J Urol (2015)

Known susceptibility SNPs for sporadic prostate cancer show a similar association with “hereditary” prostate cancer

Autor Cremers, Ruben G., Galesloot, Tessel E., Aben, Katja K., van Oort, Inge M., Vasen, Hans F., Vermeulen, Sita H., Kiemeney, Lambertus A.
Vydáno v Prostate (2015)

The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited

Autor Cremers, Ruben G., Aben, Katja K., van Oort, Inge M., Sedelaar, J.P. Michiel, Vasen, Hans F., Vermeulen, Sita H., Kiemeney, Lambertus A.
Vydáno v Prostate (2016)

Drug–drug interaction potential in men treated with enzalutamide: Mind the gap

Autor Benoist, Guillemette Emma, van Oort, Inge M., Smeenk, Stella, Javad, Adrian, Somford, Diederik M., Burger, David M., Mehra, Niven, van Erp, Nielka P.
Vydáno v Br J Clin Pharmacol (2017)

Development and validation of a bioanalytical method to quantitate enzalutamide and its active metabolite N-desmethylenzalutamide in human plasma: application to clinical managemen...

Autor Benoist, Guillemette E, van der Meulen, Eric, van Oort, Inge M, Beumer, Jan Hendrik, Somford, Diederik M, Schalken, Jack A, Burger, David M, van Erp, Nielka P
Vydáno v Ther Drug Monit (2018)

Epigenetic markers in circulating cell‐free DNA as prognostic markers for survival of castration‐resistant prostate cancer patients

Autor Hendriks, Rianne J., Dijkstra, Siebren, Smit, Frank P., Vandersmissen, Johan, Van de Voorde, Hendrik, Mulders, Peter F. A., van Oort, Inge M., Van Criekinge, Wim, Schalken, Jack A.
Vydáno v Prostate (2018)

Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI

Autor Leyten, Gisele H. J. M., Wierenga, Elisabeth A., Michiel Sedelaar, J. P., van Oort, Inge M., Futterer, Jurgen J., Barentsz, Jelle O., Schalken, Jack A., Mulders, Peter F. A.
Vydáno 2013

Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trial

Autor van Tol‐Geerdink, Julia J., Leer, Jan Willem H., Wijburg, Carl J., van Oort, Inge M., Vergunst, Henk, van Lin, Emile J., Witjes, J. Alfred, Stalmeier, Peep F. M.
Vydáno v Health Expect (2015)

Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide

Autor Benoist, Guillemette E., Hendriks, Rianne J., Mulders, Peter F. A., Gerritsen, Winald R., Somford, Diederik M., Schalken, Jack A., van Oort, Inge M., Burger, David M., van Erp, Nielka P.
Vydáno v Clin Pharmacokinet (2016)

Prior PSMA PET-CT Imaging and Hounsfield Unit Impact on Tumor Yield and Success of Molecular Analyses from Bone Biopsies in Metastatic Prostate Cancer

Autor Smits, Minke, Ekici, Kamer, Pamidimarri Naga, Samhita, van Oort, Inge M., Sedelaar, Michiel J. P., Schalken, Jack A., Nagarajah, James, Scheenen, Tom W. J., Gerritsen, Winald R., Fütterer, Jurgen J., Mehra, Niven
Vydáno v Cancers (Basel) (2020)

High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer

Autor Westdorp, Harm, Creemers, Jeroen H. A., van Oort, Inge M., Mehra, Niven, Hins-de Bree, Simone M., Figdor, Carl G., Witjes, J. Alfred, Schreibelt, Gerty, de Vries, I. Jolanda M., Gerritsen, Winald R., Ottevanger, Petronella B.
Vydáno v Front Oncol (2020)

Introducing Decision Aids into Routine Prostate Cancer Care in The Netherlands: Implementation and Patient Evaluations from the Multi-regional JIPPA Initiative

Autor Cuypers, Maarten, Al-Itejawi, Hoda H. M., van Uden-Kraan, Cornelia F., Stalmeier, Peep F. M., Lamers, Romy E. D., van Oort, Inge M., Somford, Diederik M., van Moorselaar, Reindert Jeroen A., Verdonck-de Leeuw, Irma M., van de Poll-Franse, Lonneke V., van Tol-Geerdink, Julia J., de Vries, Marieke
Vydáno v J Cancer Educ (2019)

Impact of DNA damage repair defects and aggressive variant features on response to carboplatin‐based chemotherapy in metastatic castration‐resistant prostate cancer

Autor Slootbeek, Peter H. J., Duizer, Marleen L., van der Doelen, Maarten J., Kloots, Iris S. H., Kuppen, Malou C. P., Westgeest, Hans M., Uyl‐de Groot, Carin A., Pamidimarri Naga, Samhita, Ligtenberg, Marjolijn J. L., van Oort, Inge M., Gerritsen, Winald R., Schalken, Jack A., Kroeze, Leonie I., Bloemendal, Haiko J., Mehra, Niven
Vydáno v Int J Cancer (2020)

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

Autor Westdorp, Harm, Creemers, Jeroen H. A., van Oort, Inge M., Schreibelt, Gerty, Gorris, Mark A. J., Mehra, Niven, Simons, Michiel, de Goede, Anna L., van Rossum, Michelle M., Croockewit, Alexandra J., Figdor, Carl G., Witjes, J. Alfred, Aarntzen, Erik H. J. G., Mus, Roel D. M., Brüning, Mareke, Petry, Katja, Gotthardt, Martin, Barentsz, Jelle O., de Vries, I. Jolanda M., Gerritsen, Winald R.
Vydáno v J Immunother Cancer (2019)

The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

Autor van Dessel, Lisanne F., van Riet, Job, Smits, Minke, Zhu, Yanyun, Hamberg, Paul, van der Heijden, Michiel S., Bergman, Andries M., van Oort, Inge M., de Wit, Ronald, Voest, Emile E., Steeghs, Neeltje, Yamaguchi, Takafumi N., Livingstone, Julie, Boutros, Paul C., Martens, John W. M., Sleijfer, Stefan, Cuppen, Edwin, Zwart, Wilbert, van de Werken, Harmen J. G., Mehra, Niven, Lolkema, Martijn P.
Vydáno v Nat Commun (2019)

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

Autor Privé, Bastiaan M., Janssen, Marcel J. R., van Oort, Inge M., Muselaers, Constantijn H. J., Jonker, Marianne A., de Groot, Michel, Mehra, Niven, Verzijlbergen, J. Fred, Scheenen, Tom W. J., Zámecnik, Patrik, Barentsz, Jelle O., Gotthardt, Martin, Noordzij, Walter, Vogel, Wouter V., Bergman, Andries M., van der Poel, Henk G., Vis, André N., Oprea-Lager, Daniela E., Gerritsen, Winald R., Witjes, J. Alfred, Nagarajah, James
Vydáno v BMC Cancer (2020)

Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility

Autor Gudmundsson, Julius, Sulem, Patrick, Gudbjartsson, Daniel F., Blondal, Thorarinn, Gylfason, Arnaldur, Agnarsson, Bjarni A., Benediktsdottir, Kristrun R., Magnusdottir, Droplaug N., Orlygsdottir, Gudbjorg, Jakobsdottir, Margret, Stacey, Simon N., Sigurdsson, Asgeir, Wahlfors, Tiina, Tammela, Teuvo, Breyer, Joan P., McReynolds, Kate M., Bradley, Kevin M., Saez, Berta, Godino, Javier, Navarrete, Sebastian, Fuertes, Fernando, Murillo, Laura, Polo, Eduardo, Aben, Katja K., van Oort, Inge M., Suarez, Brian K., Helfand, Brian T., Kan, Donghui, Zanon, Carlo, Frigge, Michael L., Kristjansson, Kristleifur, Gulcher, Jeffrey R., Einarsson, Gudmundur V., Jonsson, Eirikur, Catalona, William J., Mayordomo, Jose I., Kiemeney, Lambertus A., Smith, Jeffrey R., Schleutker, Johanna, Barkardottir, Rosa B., Kong, Augustine, Thorsteinsdottir, Unnur, Rafnar, Thorunn, Stefansson, Kari
Vydáno 2009

A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer

Autor Gudmundsson, Julius, Sulem, Patrick, Gudbjartsson, Daniel F., Masson, Gisli, Agnarsson, Bjarni A., Benediktsdottir, Kristrun R., Sigurdsson, Asgeir, Magnusson, Olafur Th., Gudjonsson, Sigurjon A., Magnusdottir, Droplaug N., Johannsdottir, Hrefna, Helgadottir, Hafdis Th., Stacey, Simon N., Jonasdottir, Adalbjorg, Olafsdottir, Stefania B., Thorleifsson, Gudmar, Jonasson, Jon G., Tryggvadottir, Laufey, Navarrete, Sebastian, Fuertes, Fernando, Helfand, Brian T., Hu, Qiaoyan, Csiki, Irma E., Mates, Ioan N., Jinga, Viorel, Aben, Katja K. H., van Oort, Inge M., Vermeulen, Sita H., Donovan, Jenny L., Hamdy, Freddy C., Ng, Chi-Fai, Chiu, Peter K.F., Lau, Kin-Mang, Ng, Maggie C.Y., Gulcher, Jeffrey R., Kong, Augustine, Catalona, William J., Mayordomo, Jose I., Einarsson, Gudmundur V., Barkardottir, Rosa B., Jonsson, Eirikur, Mates, Dana, Neal, David E., Kiemeney, Lambertus A., Thorsteinsdottir, Unnur, Rafnar, Thorunn, Stefansson, Kari
Vydáno 2012